Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
11 Oct 2019
Transparency notification BlackRock, Inc.
Read More
10 Oct 2019
UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases
Read More
9 Oct 2019
UCB Showcases Wealth of new Psoriasis Research at EADV 2019
Read More
8 Oct 2019
Transparency notification Wellington
Read More
8 Oct 2019
Transparency notification BlackRock, Inc.
Read More
27 Sep 2019
Transparency notification BlackRock, Inc.
Read More
25 Sep 2019
UCB presents UCB0107 anti-Tau immunotherapy Phase I study results at World Movement Disorders Conference®
Read More
24 Sep 2019
Transparency notifications BlackRock, Inc.
Read More
20 Sep 2019
Experts consider osteoporosis to be a silent epidemic which is neglected and under addressed, according to new survey released today
Read More
19 Sep 2019
Transparency notification BlackRock, Inc.
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
17
Page
18
Page
19
Page
20
Current page
21
Page
22
Page
23
Page
24
Page
25
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss